by Derek Pendlebury, PhD
Volume 5, Issue 3 (Fall 2006)
Biopharmaceutical manufacturers are constantly seeking new ways to lower production costs, while simultaneously increasing cost effectiveness without sacrificing quality. The U.S. biotech industry has grown from $8 billion in 1992 to $30 billion in 2002. As productivity in biopharmaceutical manufacturing has increased, pressures to contain costs have mounted in the healthcare industry, coupled with increased demands by investors, which results in increased cost containment pressures on the industry as a whole. Some biotechnology products need to be produced in large quantities (hundreds of kilograms per year) to meet both current and expected demand. This requires significant manufacturing capacity, and makes the types of incremental process improvements commonly sought in chemical pharmaceutical processing an attractive proposition for biopharmaceutical manufacturing…
Citation:
Pendlebury D. The Use of Disposable Systems in the Manufacture of Biopharmaceuticals. BioProcess J, 2006; 5(3): 54-58. https://doi.org/10.12665/J53.Pendlebury